What's Going On With Insurance Company Loews' Shares Monday?

Written by Emily J. Thompson, Senior Investment Analyst

Source: Benzinga

Updated: May 06 2024

0mins

ABEQ+0.05%

L-0.29%

CNA-0.34%

Should l Buy ABEQ?

Source: Benzinga

Financial Performance of Loews Corp:
- Reported a 22% increase in net income to $457 million for the first quarter FY24.
- Earnings per share (EPS) rose to $2.05 from $1.61 a year ago.
- Revenues increased to $4.23 billion from $3.78 billion in the previous year.
CNA Financial Corp Results:
- Revenue contribution grew to $3.44 billion from $3.15 billion a year ago.
- Net income increased to $310 million from $268 million due to higher net investment income.
Boardwalk Pipelines Segment:
- Revenues rose to $517 million from $397 million in the year-ago quarter.
- Net income increased to $121 million from $86 million the prior year.
Loews Hotels Performance:
- Revenues increased to $216 million from $192 million, but net income declined to $16 million from $24 million due to lower equity income.
Financial Position and Investments:
- Company had $3.2 billion in cash and investments and $1.8 billion in debt as of March-end.
- Repurchased 0.9 million shares for $67 million in the quarter.

Trade with 70% Backtested Accuracy

Stop guessing and start using high-conviction signals backed by rigorous historical data.

Analyst Views on ABEQ

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff

May 21 2025Benzinga

Fourth Quarter Financial Performance: Medtronic reported fourth-quarter 2025 sales of $8.93 billion, exceeding expectations, with adjusted EPS of $1.62 and a year-over-year revenue increase of 3.9%. The cardiovascular segment saw significant growth, while diabetes revenue rose by 10.4%.
Business Separation Announcement: Medtronic plans to separate its Diabetes business into a standalone company within 18 months, aiming for improved margins and focused growth in high-margin markets, alongside an increase in cash dividends and adjusted EPS.

What's Going On With Unilever Stock Today?

Nov 14 2024Benzinga

Unilever's Strategic Shift: Unilever PLC is exploring the sale of smaller food brands in the Netherlands and other parts of Europe to streamline its portfolio and focus on key power brands, aiming for improved profitability and long-term growth under CEO Hein Schumacher.
Legal Tensions with Ben & Jerry's: The company's strategic changes come amid a lawsuit from Ben & Jerry’s, which accuses Unilever of suppressing its support for Palestinian refugees, highlighting ongoing conflicts between the two entities.

AI Power Play: Accenture And Unilever Unveil Major Expansion to Transform Digital Operations

Sep 05 2024Benzinga

Expansion of Partnership: Accenture and Unilever are expanding their strategic partnership to enhance digital infrastructure and leverage generative AI for improved efficiency and productivity across global operations.
Implementation of GenWizard: Unilever will utilize Accenture's GenWizard platform, which includes over 350 patents, to accelerate technology development and achieve operational efficiencies, building on previous successful AI initiatives.

What's Going On With Unilever Shares Today?

Jul 12 2024Benzinga

Unilever PLC Plans Job Cuts in Europe: Unilever PLC aims to reduce one-third of its office positions in Europe by the end of 2025, eliminating up to 3,200 roles as part of growth initiatives led by the CEO.
Stock Performance and Strategic Changes: UL stock has gained over 2% in the past month, and the company is undergoing strategic changes, including a business shake-up with the spin-off of its ice cream division to drive growth.